These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 25993630

  • 1. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
    Rodan LH, Wells GD, Banks L, Thompson S, Schneiderman JE, Tein I.
    PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High cytochrome c oxidase expression links to severe skeletal energy failure by (31)P-MRS spectroscopy in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.
    Liu AH, Niu FN, Chang LL, Zhang B, Liu Z, Chen JY, Zhou Q, Wu HY, Xu Y.
    CNS Neurosci Ther; 2014 Jun; 20(6):509-14. PubMed ID: 24674659
    [Abstract] [Full Text] [Related]

  • 4. Molecular pathology of MELAS and L-arginine effects.
    Koga Y, Povalko N, Nishioka J, Katayama K, Yatsuga S, Matsuishi T.
    Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
    [Abstract] [Full Text] [Related]

  • 5. MELAS: Monitoring treatment with magnetic resonance spectroscopy.
    Hovsepian DA, Galati A, Chong RA, Mazumder R, DeGiorgio CM, Mishra S, Yim C.
    Acta Neurol Scand; 2019 Jan; 139(1):82-85. PubMed ID: 30216413
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Magnetic resonance spectroscopy in patients with MELAS.
    Möller HE, Kurlemann G, Pützler M, Wiedermann D, Hilbich T, Fiedler B.
    J Neurol Sci; 2005 Mar 15; 229-230():131-9. PubMed ID: 15760631
    [Abstract] [Full Text] [Related]

  • 8. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.
    El-Hattab AW, Emrick LT, Chanprasert S, Craigen WJ, Scaglia F.
    Int J Biochem Cell Biol; 2014 Mar 15; 48():85-91. PubMed ID: 24412347
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin.
    Penn AM, Lee JW, Thuillier P, Wagner M, Maclure KM, Menard MR, Hall LD, Kennaway NG.
    Neurology; 1992 Nov 15; 42(11):2147-52. PubMed ID: 1436526
    [Abstract] [Full Text] [Related]

  • 11. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.
    Yoneda M, Ikawa M, Arakawa K, Kudo T, Kimura H, Fujibayashi Y, Okazawa H.
    Biochim Biophys Acta; 2012 May 15; 1820(5):615-8. PubMed ID: 21600268
    [Abstract] [Full Text] [Related]

  • 12. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes].
    Sudo A, Sano H, Kawamura N.
    No To Hattatsu; 2014 Jan 15; 46(1):39-43. PubMed ID: 24620430
    [Abstract] [Full Text] [Related]

  • 13. Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.
    El-Hattab AW, Emrick LT, Hsu JW, Chanprasert S, Almannai M, Craigen WJ, Jahoor F, Scaglia F.
    Mol Genet Metab; 2016 Apr 15; 117(4):407-12. PubMed ID: 26851065
    [Abstract] [Full Text] [Related]

  • 14. High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.
    Guerrero-Molina MP, Morales-Conejo M, Delmiro A, Morán M, Domínguez-González C, Arranz-Canales E, Ramos-González A, Arenas J, Martín MA, de la Aleja JG.
    Eur J Neurol; 2023 Feb 15; 30(2):538-547. PubMed ID: 36334048
    [Abstract] [Full Text] [Related]

  • 15. ATP, phosphocreatine and lactate in exercising muscle in mitochondrial disease and McArdle's disease.
    Löfberg M, Lindholm H, Näveri H, Majander A, Suomalainen A, Paetau A, Sovijärvi A, Härkönen M, Somer H.
    Neuromuscul Disord; 2001 May 15; 11(4):370-5. PubMed ID: 11369188
    [Abstract] [Full Text] [Related]

  • 16. Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS).
    Li X, Wang Y, Wang Z, Lu J, Xu Y, Ye J, Kuang Z, Li B, Pan M, Chen W, Lu S, Zhou Z, Cheng L, Wang H.
    J Clin Neurosci; 2018 Sep 15; 55():65-70. PubMed ID: 29921486
    [Abstract] [Full Text] [Related]

  • 17. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.
    Niu FN, Meng HL, Chang LL, Wu HY, Li WP, Liu RY, Wang HT, Zhang B, Xu Y.
    CNS Neurosci Ther; 2017 Aug 15; 23(8):686-697. PubMed ID: 28695670
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effect of L-arginine for stroke-like episode in MELAS.
    Kubota M, Sakakihara Y, Mori M, Yamagata T, Momoi-Yoshida M.
    Brain Dev; 2004 Oct 15; 26(7):481-3; discussion 480. PubMed ID: 15351086
    [Abstract] [Full Text] [Related]

  • 19. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
    Desquiret-Dumas V, Gueguen N, Barth M, Chevrollier A, Hancock S, Wallace DC, Amati-Bonneau P, Henrion D, Bonneau D, Reynier P, Procaccio V.
    Biochim Biophys Acta; 2012 Jun 15; 1822(6):1019-29. PubMed ID: 22306605
    [Abstract] [Full Text] [Related]

  • 20. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.
    Ganetzky RD, Falk MJ.
    Mol Genet Metab; 2018 Mar 15; 123(3):301-308. PubMed ID: 29428506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.